Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 9/2017

Open Access 01-09-2017 | Original Article – Clinical Oncology

Surgical treatment of advanced penile cancer

Authors: Ke Zhang, Xiang Wan, Huan Xu, Wenzhi Li, Juan Zhou, Ming-Xi Xu, Hai-Jun Yao, Zhong Wang

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2017

Login to get access

Abstract

Purpose

To evaluate the therapeutic effect of surgery in patients with advanced penile cancer, who have a dismal prognosis.

Patients and methods

Between September 2007 and July 2015, we treated 12 patients with surgical therapy.

Results

The median follow-up period for all the patients was 16 months (range 4–60 months). The outcome and concomitant symptoms were analyzed, and the survival rates were calculated. Three of the patients are currently alive. The median overall survival of the patients was 9 months (range 4–13 months).

Conclusion

The present results suggest that surgery is a valuable treatment option for patients with advanced penile cancer. The prognosis of advanced penile cancer is closely related to lymph node and distant metastases. Flap repair can solve the problem of large area skin defect. Advanced penile cancer is difficult to treat regardless of chemotherapy or radiotherapy, and surgery cannot prolong the lives of patients. However, the dissection of lesions and repair of large area skin defects can dramatically improve the quality of life of patients, especially those with locally advanced disease without distant metastasis.
Literature
go back to reference Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23:8706–8712. doi:10.1200/JCO.2005.02.8852 CrossRefPubMed Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23:8706–8712. doi:10.​1200/​JCO.​2005.​02.​8852 CrossRefPubMed
go back to reference Clark PE, Spiess PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro L, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M (2013) Penile cancer: clinical practice guidelines in oncology. J Natl Compr Cancer Netw 11:594–615CrossRef Clark PE, Spiess PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro L, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M (2013) Penile cancer: clinical practice guidelines in oncology. J Natl Compr Cancer Netw 11:594–615CrossRef
go back to reference Di Lorenzo G, Cartenì G, Autorino R, Gonnella A, Perdonà S, Ferro M, Longo N, Rescigno P, Doria F, Faiella A, Altieri V, Palmieri G, Imbimbo C, Mirone V, De Placido S (2009) Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients. Anticancer Drugs 20:277–280. doi:10.1097/CAD.0b013e328329a293 CrossRefPubMed Di Lorenzo G, Cartenì G, Autorino R, Gonnella A, Perdonà S, Ferro M, Longo N, Rescigno P, Doria F, Faiella A, Altieri V, Palmieri G, Imbimbo C, Mirone V, De Placido S (2009) Activity and toxicity of paclitaxel in pretreated metastatic penile cancer patients. Anticancer Drugs 20:277–280. doi:10.​1097/​CAD.​0b013e328329a293​ CrossRefPubMed
go back to reference Komine N, Narita S, Kigure T, Tsuruta H, Numakura K, Akihama S, Saito M, Inoue T, Tsuchiya N, Satoh S, Nanjo H, Habuchi T (2014) Successful local control of recurrent penile cancer treated with a combination of systemic chemotherapy, irradiation, and mohs’ paste: a case report. Case Rep Oncol 7:522–527. doi:10.1159/000365809 CrossRefPubMedPubMedCentral Komine N, Narita S, Kigure T, Tsuruta H, Numakura K, Akihama S, Saito M, Inoue T, Tsuchiya N, Satoh S, Nanjo H, Habuchi T (2014) Successful local control of recurrent penile cancer treated with a combination of systemic chemotherapy, irradiation, and mohs’ paste: a case report. Case Rep Oncol 7:522–527. doi:10.​1159/​000365809 CrossRefPubMedPubMedCentral
go back to reference Ravi R (1993) Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 72:817–819CrossRefPubMed Ravi R (1993) Correlation between the extent of nodal involvement and survival following groin dissection for carcinoma of the penis. Br J Urol 72:817–819CrossRefPubMed
go back to reference Srinivas V, Morse MJ, Herr HW, Sogani PC, Whitmore WF Jr (1987) Penile cancer: relation of extent of nodal metastasis to survival. J Urol 137:880–882CrossRefPubMed Srinivas V, Morse MJ, Herr HW, Sogani PC, Whitmore WF Jr (1987) Penile cancer: relation of extent of nodal metastasis to survival. J Urol 137:880–882CrossRefPubMed
go back to reference Svatek RS, Munsell M, Kincaid JM, Hegarty P, Slaton JW, Busby JE, Gaston KE, Spiess PE, Pagliaro LC, Tamboli P, Pettaway CA (2009) Association between lymph node density and disease specific survival in patients with penile cancer. J Urol 182:2721–2727. doi:10.1016/j.juro.2009.08.029 CrossRefPubMed Svatek RS, Munsell M, Kincaid JM, Hegarty P, Slaton JW, Busby JE, Gaston KE, Spiess PE, Pagliaro LC, Tamboli P, Pettaway CA (2009) Association between lymph node density and disease specific survival in patients with penile cancer. J Urol 182:2721–2727. doi:10.​1016/​j.​juro.​2009.​08.​029 CrossRefPubMed
go back to reference Vinh-Hung V, Nguyen NP, Cserni G, Truong P, Woodward W, Verkooijen HM, Promish D, Ueno NT, Tai P, Nieto Y, Joseph S, Janni W, Vicini F, Royce M, Storme G, Wallace AM, Vlastos G, Bouchardy C, Hortobagyi GN (2009a) Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. Future Oncol 5:1585–1603. doi:10.2217/fon.09.129 CrossRefPubMed Vinh-Hung V, Nguyen NP, Cserni G, Truong P, Woodward W, Verkooijen HM, Promish D, Ueno NT, Tai P, Nieto Y, Joseph S, Janni W, Vicini F, Royce M, Storme G, Wallace AM, Vlastos G, Bouchardy C, Hortobagyi GN (2009a) Prognostic value of nodal ratios in node-positive breast cancer: a compiled update. Future Oncol 5:1585–1603. doi:10.​2217/​fon.​09.​129 CrossRefPubMed
go back to reference Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G, Deglise C, Usel M, Lutz JM, Bouchardy C (2009b) Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 27:1062–1068. doi:10.1200/JCO.2008.18.6965 CrossRefPubMed Vinh-Hung V, Verkooijen HM, Fioretta G, Neyroud-Caspar I, Rapiti E, Vlastos G, Deglise C, Usel M, Lutz JM, Bouchardy C (2009b) Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol 27:1062–1068. doi:10.​1200/​JCO.​2008.​18.​6965 CrossRefPubMed
Metadata
Title
Surgical treatment of advanced penile cancer
Authors
Ke Zhang
Xiang Wan
Huan Xu
Wenzhi Li
Juan Zhou
Ming-Xi Xu
Hai-Jun Yao
Zhong Wang
Publication date
01-09-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 9/2017
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-017-2435-1

Other articles of this Issue 9/2017

Journal of Cancer Research and Clinical Oncology 9/2017 Go to the issue